Following my cortisol blood test, I've spoken with several doctors to better understand my "high cortisol" results and answer ...

Cautious investors have long known that healthcare spending rises steadily regardless of the direction of the overall economy ...

Quest Diagnostics and Elevance Health are broadening their partnership into four more states with the goal of making it ...

On Friday, Quest Diagnostics Inc (DGX) stock saw a modest uptick, ending the day at $160.44 which represents a slight increase of $3.60 or 2.30% from the prior close of $156.84. The stock opened at ...

Apollon Wealth Management LLC lowered its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 10.4% ...

Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

StockNews.com lowered shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a report ...

Quest Diagnostics Inc.’s DGX robust Advanced Diagnostics offering is poised to drive its growth in the upcoming quarters. Strength in the company’s core business is highly encouraging. Additionally, a ...

Quest Diagnostics (DGX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.